
In an interview with Pharmacy Times, Thomas Hope, MD, explains how earlier consideration of peptide receptor radionuclide therapy in neuroendocrine tumors makes treatment scheduling and continuity of care essential opportunities for pharmacists.
Catch up with the most read articles of the week on Specialty Pharmacy Times.
[<a href="//storify.com/pharmacytimes/medicare-not-helping-chemo-drug-cost-tops-specialt" target="_blank">View the story "Medicare Not Helping Chemo Drug Cost Tops Specialty Pharmacy Week in Review" on Storify</a>]





